Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone”

941 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 941 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658183
What this trial is testing

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Shanghai Best-Link Bioscience, LLC 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Not applicableUnknownNCT04860037
What this trial is testing

Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients

Who this might be right for
Acromegaly
University Hospital, Montpellier 250
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Large-scale testing (Phase 3)Study completedNCT00600886
What this trial is testing

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 358
Large-scale testing (Phase 3)Study completedNCT04786873
What this trial is testing

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

Who this might be right for
Growth Hormone Deficiency
AEterna Zentaris 101
Very early researchUnknownNCT05660356
What this trial is testing

Growth Hormone Deficiency in Mild Traumatic Brain Injury

Who this might be right for
Growth Hormone TreatmentGrowth Hormone DeficiencyConcussion, Mild+1 more
University of Calgary 20
Early research (Phase 1)Study completedNCT02012556
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

Who this might be right for
HIV
Theratechnologies 18
Not applicableUnknownNCT06455956
What this trial is testing

Use of miRNAs in Growth Hormone Deficiency (GHD)

Who this might be right for
Growth Hormone Deficiency
University of Parma 400
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Not applicableStudy completedNCT00397592
What this trial is testing

Growth Hormone's Effect on Endothelial Progenitor Cells

Who this might be right for
Cardiovascular Disease
Vanderbilt University 18
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Not applicableUnknownNCT02322034
What this trial is testing

Interval Training and Hormones in Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Federico II University 80
Very early researchNot Yet RecruitingNCT07671092
What this trial is testing

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Who this might be right for
Metastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more
RayzeBio, Inc. 40
Not applicableStudy completedNCT06307457
What this trial is testing

HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Who this might be right for
Breast Cancer
Pfizer 604
Large-scale testing (Phase 3)Study completedNCT00294164
What this trial is testing

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Who this might be right for
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections
EMD Serono 245
Not applicableNot Yet RecruitingNCT07815600
What this trial is testing

Pistachio Consumption in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Stages 3b-5)
Shahid Beheshti University of Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT03560531
What this trial is testing

ZN-c5 in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 181
Large-scale testing (Phase 3)Study completedNCT00557336
What this trial is testing

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

Who this might be right for
Foetal Growth ProblemSmall for Gestational Age
Novo Nordisk A/S 160
Next Page